Company Overview of Warp Drive Bio, LLC
Warp Drive Bio, LLC develops genomic technology to discover drugs of natural origin. The company also engages in development of drugs. Warp Drive Bio, LLC was incorporated in 2010 and is based in Cambridge, Massachusetts.
215 First Street
Cambridge, MA 02142
Founded in 2010
Key Executives for Warp Drive Bio, LLC
Chief Executive Officer and President
Founder and Executive Chairman
Co-Founder, Chairman of the Scientific Advisory Board and Director
Compensation as of Fiscal Year 2017.
Warp Drive Bio, LLC Key Developments
Warp Drive Bio, LLC Presents at The 24th Annual Future Leaders in the Biotech Industry Conference, Apr-07-2017 08:30 AM
Jan 29 17
Warp Drive Bio, LLC Presents at The 24th Annual Future Leaders in the Biotech Industry Conference, Apr-07-2017 08:30 AM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.
Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors
Oct 17 16
Warp Drive Bio announced that Steven H. Holtzman will join the company’s board of directors. Mr. Holtzman brings to Warp Drive Bio more than 30 years of leadership experience in the biotechnology industry. Mr. Holtzman comes to Warp Drive Bio as the current chief executive officer for Decibel Therapeutics. Prior to Decibel, he served as the executive vice president, corporate development at Biogen Inc., where he lead the leadership
team through six new drug approvals. Mr. Holtzman also held positions at Infinity Pharmaceuticals Inc., where he served as founder, chief executive officer and chair of the board of directors. Previously, he was the chief business officer of Millennium Pharmaceuticals, now Takeda Oncology and prior to that a founder, board member and executive vice president of DNX Corporation. Mr. Holtzman is a member of the boards of directors for PMV Pharma, Visterra, Humatics, The Sync Project and Molecular Partners. He is also currently a trustee of the Berklee College of Music and has previously served on the board of trustees for the Hastings Center for Ethics and the Life Sciences.
Warp Drive Bio Appoints Rachel K. King to Board of Directors
Jul 13 16
Warp Drive Bio announced that Rachel K. King will join the company’s board of directors. Ms. King brings to Warp Drive Bio over 25 years of biotechnology leadership experience. Ms. King has spent the last 13 years serving as chief executive officer for GlycoMimetics Inc. Prior to that, she spent two years at New Enterprise Associates where she served as an entrepreneur-in-residence.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries